How should I manage an ECG that shows normal sinus rhythm, nonspecific ST‑T wave changes, and first‑degree atrioventricular (AV) block?

Management of Normal Sinus Rhythm with Nonspecific ST-T Wave Changes and First-Degree AV Block

In an asymptomatic patient, this ECG requires no immediate intervention but warrants careful evaluation for underlying cardiovascular risk factors and surveillance for progression. 1

Immediate Assessment

Determine whether the patient is symptomatic:

• Ask specifically about syncope, presyncope, dyspnea, chest pain, palpitations, or exercise intolerance 1
• Assess for symptoms resembling pacemaker syndrome (fatigue, dyspnea, reduced exercise tolerance) particularly if PR interval exceeds 300 ms 1, 2
• Evaluate for hemodynamic compromise through physical examination (signs of heart failure, hypotension) 1

If the patient is asymptomatic, permanent pacemaker implantation is not indicated, even when premature ventricular complexes are present. 1 The 2018 ACC/AHA/HRS guidelines reserve pacing only for patients with hemodynamic compromise or higher-grade block 3, 1.

Risk Stratification

First-degree AV block is not entirely benign and requires ongoing surveillance:

• It is associated with increased risk of atrial fibrillation, heart failure hospitalization, and mortality in patients with underlying cardiovascular disease 4, 5, 6
• The PR interval itself may be a marker of more advanced cardiac disease 5, 7
• Patients with coronary artery disease and first-degree AV block have a 2.33-fold increased risk of heart failure hospitalization 6

Evaluate for comorbidities that increase risk:

• Screen for hypertension, heart failure, coronary artery disease, and structural heart disease 5
• Obtain echocardiography if not recently performed to assess left ventricular function and exclude structural abnormalities 1
• Consider stress testing if symptoms occur with exertion, as the PR interval may fail to adapt appropriately during exercise 2, 7

Medication Management

Avoid AV-nodal blocking agents unless carefully considered:

• Beta-blockers and non-dihydropyridine calcium-channel blockers (diltiazem, verapamil) should be avoided in patients with AV block beyond first-degree, decompensated heart failure, hypotension, or reactive airway disease 1
• Non-dihydropyridine calcium-channel blockers are contraindicated for PVC suppression when any AV block greater than first-degree is present 1
• If beta-blockers are needed for hypertension or PVC suppression and AV conduction is otherwise normal, they can be used cautiously 1

For hypertension management, prioritize ACE inhibitors or ARBs:

• These agents lower left ventricular mass, limit atrial enlargement progression, and may decrease incident atrial fibrillation 1
• Target blood pressure < 140/90 mm Hg for general hypertensive population; < 130/80 mm Hg may be pursued in patients with multiple cardiovascular risk factors 1

Addressing Nonspecific ST-T Wave Changes

Nonspecific ST-T wave changes represent primary repolarization abnormalities that may indicate underlying myocardial changes:

• These changes can be caused by ischemia, myocarditis, drugs, toxins, electrolyte abnormalities (particularly calcium and potassium), or other metabolic derangements 8
• They are increasingly recognized as predictors of cardiovascular morbidity and mortality, not merely benign findings 9
• Obtain baseline electrolytes (potassium, calcium, magnesium) and correct any abnormalities 8
• Review all medications for potential QT-prolonging or repolarization-affecting drugs 8

Consider cardiovascular risk reduction strategies:

• Initiate statin therapy in hypertensive patients as an additional cardiovascular risk-reduction strategy 1
• In adults ≥ 40 years with hypertension and dyslipidemia, combined therapy with an ACE inhibitor (or ARB), aspirin, and a statin is recommended to lower cardiovascular event rates 1
• Obtain baseline fasting or non-fasting lipid panel before initiating therapy 1

Surveillance and Red Flags

Monitor for progression of conduction disease:

• Progressive PR-interval prolongation beyond 300 ms is a red flag indicating possible need for pacing 1
• Transition to second-degree or third-degree AV block constitutes a red flag and should prompt immediate assessment for pacing 1
• Development of symptoms such as syncope, presyncope, dyspnea, chest pain, or palpitations warrants urgent re-evaluation 1

Repeat ECG at regular intervals:

• Establish a baseline and monitor for changes in PR interval, QRS duration, and ST-T wave morphology 1
• Consider ambulatory ECG monitoring if symptoms are intermittent or exercise-related 2

Common Pitfalls to Avoid

• Do not assume first-degree AV block is entirely benign in patients with cardiovascular risk factors; ongoing surveillance for progression is essential 1
• Avoid prescribing AV-nodal blocking agents without evaluating cumulative effects on AV conduction, especially when the PR interval is already prolonged 1
• Do not dismiss nonspecific ST-T wave changes as insignificant; they may predict cardiovascular morbidity and mortality 9
• Atropine is ineffective for bradycardia caused by type II second-degree or third-degree AV block below the AV node and should not be used in this setting 1